Sebastian Brandner
University College London
H-index: 87
Europe-United Kingdom
Top articles of Sebastian Brandner
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Versatile, accessible cross-platform molecular profiling of central nervous system tumors: web-based, prospective multi-center validation | Felix Sahm Areeba Patel Kirsten Göbel Felix Hinz Sebastian Ille | 2024/4/10 | |
Interictal Electrical Source Imaging | Journal of Clinical Neurophysiology | Stefan Rampp Nadia Müller-Voggel Hajo Hamer Arnd Doerfler Sebastian Brandner | 2024/1/1 |
Extracting structured information from unstructured histopathology reports using generative pre‐trained transformer 4 (GPT‐4) | The Journal of Pathology | Daniel Truhn Chiara ML Loeffler Gustav Müller‐Franzes Sven Nebelung Katherine J Hewitt | 2024/3 |
Defining benchmark outcomes for mesial temporal lobe epilepsy surgery: A global multicenter analysis of 1119 cases | Epilepsia | Richard Drexler Franz L Ricklefs Sharona Ben‐Haim Anna Rada Friedrich Wörmann | 2024/2/24 |
Nerve biopsy in T-cell lymphoma with neurolymphomatosis: where and when | Practical Neurology | Menelaos Pipis Zane Jaunmuktane Teresa Marafioti Sebastian Brandner Elaine C Smith | 2024/1/24 |
Neuropathology: Introduction to History, Diagnostic Approaches, Techniques and their Interpretation | Neurology: A Queen Square Textbook | Sebastian Brandner | 2024/5/13 |
Harmonized single-cell landscape, tumor architecture, and intercellular crosstalk ofIDH-wildtype glioblastoma | Cristian Ruiz-Moreno Sergio Marco Salas Erik Samuelsson Marco Grillo Sebastian Brandner | 2024 | |
Isocitrate Dehydrogenase 1/2 Wildtype Adult Astrocytoma with WHO Grade 2/3 Histological Features: Molecular Re-Classification, Prognostic Factors, Clinical Outcomes | Biomedicines | Meetakshi Gupta Mustafa Anjari Sebastian Brandner Naomi Fersht Elena Wilson | 2024/4/18 |
Correction: Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas | Acta Neuropathologica | Justin Z Wang Vikas Patil Jeff Liu Helin Dogan Ghazaleh Tabatabai | 2023 |
MEG node degree for focus localization: comparison with invasive EEG | Biomedicines | Stefan Rampp Martin Kaltenhäuser Nadia Müller-Voggel Arnd Doerfler Burkhard S Kasper | 2023/2/2 |
517P Differentiating IDH-wildtype and IDH-mutant high grade gliomas with deep learning | Annals of Oncology | KJ Hewitt CML Loeffler M Van Treeck H Muti G Veldhuizen | 2023/10/1 |
OS07. 6. A INVESTIGATING REGIONAL HETEROGENEITY AND PROGRESSION-ASSOCIATED MARKERS IN OLIGODENDROGLIOMAS | Neuro-Oncology | TO Millner H Mikaeili A Shabbir A Lowe S Brandner | 2023/9/8 |
Time‐dependent risk factors for epileptic seizures in glioblastoma patients: A retrospective analysis of 520 cases | Epilepsia | Jenny Stritzelberger Anna Gesmann Imke Fuhrmann Sebastian Brandner Tamara M Welte | 2023/7 |
Clinical implementation of integrated molecular‐morphologic risk prediction for meningioma | Brain Pathology | Thomas Hielscher Martin Sill Philipp Sievers Damian Stichel Sebastian Brandner | 2023/5 |
HGG-15. HIGH-GRADE GLIOMAS OCCURRING IN TEENAGERS AND YOUNG ADULT PATIENTS COMPRISE NOVEL MOLECULAR SUBGROUPS | Neuro-Oncology | Matthew Clarke Rita Pereira Alan Mackay Yura Grabovska Amelia Clarke | 2023/6 |
Amplification of the PLAG-family genes—PLAGL1 and PLAGL2—is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification | Acta neuropathologica | Michaela-Kristina Keck Martin Sill Andrea Wittmann Piyush Joshi Damian Stichel | 2023/1 |
Clinical, Imaging and Neurogenetic Features of Patients with Gliomatosis Cerebri Referred to a Tertiary Neuro-Oncology Centre | Journal of Personalized Medicine | David Doig Lewis Thorne Jeremy Rees Naomi Fersht Michael Kosmin | 2023/1/27 |
P18. 10. B WHICH MENINGIOMAS BENEFIT MOST FROM METHYLATION PROFILING? | Neuro-Oncology | F Ruiz L D'Antona M Dutt P Mariathasan A Merve | 2023/9/1 |
BRAIN TUMOUR GENETIC NETWORK SIGNATURES SUPERIORLY FORECAST SURVIVAL | Neuro-Oncology | James Ruffle Samia Mohinta Guilherme Pombo Robert Gray Valeriya Kopanitsa | 2023/10/1 |
STEM-02. SYNGN: A NOVEL EPIGENETIC PLATFORM FOR PATIENT-SPECIFIC DRUG-MATCHING IN GLIOBLASTOMA | Neuro-Oncology | Claire Vinel James Boot Radu Zabet Sebastian Brandner Silvia Marino | 2023/11/10 |
Co-Authors
